USD 0.63
(4.99%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 1.01 Million USD | 4816.77% |
2023 | 260.24 Thousand USD | -2.57% |
2022 | 267.12 Thousand USD | -18.36% |
2021 | 327.17 Thousand USD | -20.37% |
2020 | 410.88 Thousand USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 1.15 Million USD | -9.62% |
2024 Q3 | 1.07 Million USD | -10.83% |
2024 Q4 | 1.01 Million USD | 6578.37% |
2024 FY | 1.01 Million USD | 290.76% |
2024 Q1 | 1.23 Million USD | -8.65% |
2023 Q1 | 250.4 Thousand USD | -6.26% |
2023 Q2 | 233.65 Thousand USD | -6.69% |
2023 Q4 | 260.24 Thousand USD | 18.53% |
2023 FY | 260.24 Thousand USD | -2.57% |
2023 Q3 | 219.56 Thousand USD | -6.03% |
2022 Q4 | 267.12 Thousand USD | 91.15% |
2022 FY | 267.12 Thousand USD | -18.36% |
2022 Q2 | 148.13 Thousand USD | -53.77% |
2022 Q1 | 320.43 Thousand USD | -2.06% |
2022 Q3 | 139.74 Thousand USD | -5.66% |
2021 Q2 | 381.61 Thousand USD | 170.94% |
2021 Q3 | 353.4 Thousand USD | -7.39% |
2021 FY | 327.17 Thousand USD | -20.37% |
2021 Q1 | 140.84 Thousand USD | -65.72% |
2021 Q4 | 327.17 Thousand USD | -7.42% |
2020 Q4 | 410.88 Thousand USD | 11.72% |
2020 Q1 | 356.54 Thousand USD | 0.0% |
2020 Q2 | 350.4 Thousand USD | -1.72% |
2020 Q3 | 367.77 Thousand USD | 4.96% |
2020 FY | 410.88 Thousand USD | 0.0% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | -100.0% |
2015 Q3 | 68.56 Thousand USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acutus Medical, Inc. | 32.65 Million USD | 96.886% |
Biotricity, Inc. | 10.85 Million USD | 90.632% |
Cell MedX Corp. | - USD | -Infinity% |
Dynatronics Corporation | 3.25 Million USD | 68.791% |
Nemaura Medical Inc. | 3.08 Million USD | 67.065% |
RetinalGenix Technologies Inc. | - USD | -Infinity% |
Sonendo, Inc. | 14.03 Million USD | 92.754% |
Telesis Bio, Inc. | 5.26 Million USD | 80.7% |
Talis Biomedical Corporation | 16.78 Million USD | 93.942% |
Viveve Medical, Inc. | 5.12 Million USD | 80.154% |